Oncology

Latest News

data growth | Image credit: Suriya - stock.adobe.com
Global Biosimilar Market Projected to Reach $1.3 Trillion by 2032

April 11th 2024

The global biosimilar market is projected to surge from $25.1 billion in 2022 to approximately $1.3 trillion by 2032, with a compound annual growth rate of 17.6%, driven mainly by the increasing prevalence of cancer and the cost-effectiveness of biosimilars, as outlined in a report by Towards Healthcare.

biosimilars check-in banner
Biosimilar Business Recap: BI Layoffs; Teva, mAbxience Partnership; Phase 3 Keytruda Biosimilar Trial

April 8th 2024

biologics and money | Image credit: gopixa - stock.adobe.com
Study: More Biosimilar Competition Is Not Lowering Patient OOP Costs

March 29th 2024

money health | Image credit: utah51 - stock.adobe.com
Coherus Biosciences Cites Biosimilars as Main Drivers of 2023 Revenue Growth

March 14th 2024

prefilled syringes | Image credit: SOPONE - stock.adobe.com
Posters From AMCCBS and AAD Showcase New Technology for Biosimilar Uptake, Barriers to Self-Injectable Biologics

March 14th 2024

Latest CME Events & Activities
© 2024 MJH Life Sciences

All rights reserved.